ArticleFrontiers in neurology2025
Image-guided optimization of current steering in STN-DBS for Parkinson's disease.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Image-guided programming improves motor control in chronic subthalamic nucleus deep brain stimulation in Parkinson's disease: A prospective study.Journal of Parkinson's disease · 2026Article
- Long-lasting concordance between imaging-guided and clinical-based STN-DBS programming enhances motor and axial outcomes in Parkinson's disease: A 3-year single-center study.Journal of Parkinson's disease · 2026Article
- Deep Brain Stimulation as a Rehabilitation Amplifier: A Precision-Oriented, Network-Guided Framework for Functional Restoration in Movement Disorders.Journal of clinical medicine · 2026Review
- Validation of automated image-guided programming in STN-DBS for Parkinson's disease.Frontiers in human neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Recent advancements in multiple independent current control (MICC) technology, combined with directional leads, have improved clinical outcomes in subthalamic nucleus deep brain stimulation (STN-DBS) for Parkinson's disease (PD). However, these advancements have also increased the complexity and duration of programming. This study aimed to evaluate the clinical utility of image-guided programming (IGP) in patients with stable postoperative symptoms. Methods: Sixteen patients with advanced PD, who had undergone STN-DBS and exhibited stable symptoms for at least 6 months under conventional programming, were enrolled. An alternative stimulation program was developed using Stimview™ XT, a patient-specific image-guided interface, without altering pulse width or frequency. Stimulation fields were modified using horizontal and vertical current steering based on individual STN anatomy. Motor function was evaluated via the Unified Parkinson's Disease Rating Scale part III (UPDRS III) before, 1 h after, and 3 months post-reprogramming. Results: Image-guided current steering resulted in modifications in 29 of the 32 leads. Horizontal steering was newly introduced in 23 leads, while vertical adjustments were made in six leads. Nine patients reported immediate subjective improvement, and 15 of 16 opted to continue with the IGP-derived settings. Statistically significant improvements in Unified Parkinson's Disease Rating Scale (UPDRS) part III scores were observed 1 h after reprogramming ( Conclusions: IGP provides a clinically effective, time-efficient strategy for refining current steering in STN-DBS, even in patients with stable symptoms under conventional settings. By leveraging individualized anatomical visualization, IGP enhances precision in targeting the dorsolateral STN, resulting in improved motor outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.